Cargando…
“PFH/AGM-CBA/HSV-TK/LIPOSOME-Affibody”: Novel Targeted Nano Ultrasound Contrast Agents for Ultrasound Imaging and Inhibited the Growth of ErbB2-Overexpressing Gastric Cancer Cells
OBJECTIVE: Gastric cancer is one of the most lethal malignancies in the world. However, the current research on the diagnosis and treatment of nano-ultrasound contrast agents in the field of tumor is mostly focused on breast cancer, ovarian cancer, prostate cancer, liver cancer, etc. Due to the inte...
Autores principales: | Zhou, Houren, Liu, Hui, Zhang, Yue, Xin, Ying, Huang, Chi, Li, Mingzhong, Zhao, Xiaoyun, Ding, Pingtian, Liu, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124479/ https://www.ncbi.nlm.nih.gov/pubmed/35611358 http://dx.doi.org/10.2147/DDDT.S351623 |
Ejemplares similares
-
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
por: Ueno, Sho, et al.
Publicado: (2020) -
BDA AGMs
Publicado: (2023) -
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014) -
The functions of the multi-tasking Pfh1(Pif1) helicase
por: Sabouri, Nasim
Publicado: (2017) -
Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)